Finding a new way to measure energy in the eyes of patients with retinitis pigmentosa
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker
This study is looking at how we can better understand and treat retinitis pigmentosa by using a special imaging technique to see how well the cells in your retina are working, which could help doctors create more personalized treatment plans for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10931516 on NIH RePORTER |
What this research studies
This research focuses on retinitis pigmentosa (RP), a condition that causes progressive vision loss and blindness due to the death of light-sensitive cells in the retina. The study aims to develop a non-invasive biomarker that can assess mitochondrial performance in patients, which is crucial for understanding the disease's progression and tailoring treatments. By using optical coherence tomography (OCT), researchers will analyze changes in the inner segment ellipsoid zone (ISez) of the retina under different light conditions. This innovative approach seeks to provide a more personalized understanding of RP, moving away from a one-size-fits-all treatment strategy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa, particularly those experiencing vision loss.
Not a fit: Patients with retinitis pigmentosa who are not experiencing any symptoms or have advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for patients with retinitis pigmentosa.
How similar studies have performed: While the approach of using OCT to assess mitochondrial performance is innovative, similar methodologies have shown promise in other areas of retinal research.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Berkowitz, Bruce a. — Wayne State University
- Study coordinator: Berkowitz, Bruce a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.